BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26887776)

  • 1. Genetic differences between paediatric and adult Burkitt lymphomas.
    Havelange V; Pepermans X; Ameye G; Théate I; Callet-Bauchu E; Barin C; Penther D; Lippert E; Michaux L; Mugneret F; Dastugue N; Raphaël M; Vikkula M; Poirel HA
    Br J Haematol; 2016 Apr; 173(1):137-44. PubMed ID: 26887776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
    Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
    Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
    Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
    Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
    Gebauer N; Bernard V; Feller AC; Merz H
    Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
    Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
    Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.
    Wagener R; Aukema SM; Schlesner M; Haake A; Burkhardt B; Claviez A; Drexler HG; Hummel M; Kreuz M; Loeffler M; Rosolowski M; López C; Möller P; Richter J; Rohde M; Betts MJ; Russell RB; Bernhart SH; Hoffmann S; Rosenstiel P; Schilhabel M; Szczepanowski M; Trümper L; Klapper W; Siebert R; ;
    Genes Chromosomes Cancer; 2015 Sep; 54(9):555-64. PubMed ID: 26173642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.
    Richter J; Schlesner M; Hoffmann S; Kreuz M; Leich E; Burkhardt B; Rosolowski M; Ammerpohl O; Wagener R; Bernhart SH; Lenze D; Szczepanowski M; Paulsen M; Lipinski S; Russell RB; Adam-Klages S; Apic G; Claviez A; Hasenclever D; Hovestadt V; Hornig N; Korbel JO; Kube D; Langenberger D; Lawerenz C; Lisfeld J; Meyer K; Picelli S; Pischimarov J; Radlwimmer B; Rausch T; Rohde M; Schilhabel M; Scholtysik R; Spang R; Trautmann H; Zenz T; Borkhardt A; Drexler HG; Möller P; MacLeod RA; Pott C; Schreiber S; Trümper L; Loeffler M; Stadler PF; Lichter P; Eils R; Küppers R; Hummel M; Klapper W; Rosenstiel P; Rosenwald A; Brors B; Siebert R;
    Nat Genet; 2012 Dec; 44(12):1316-20. PubMed ID: 23143595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab.
    Forero-Castro M; Robledo C; Lumbreras E; Benito R; Hernández-Sánchez JM; Hernández-Sánchez M; García JL; Corchete-Sánchez LA; Tormo M; Barba P; Menárguez J; Ribera J; Grande C; Escoda L; Olivier C; Carrillo E; García de Coca A; Ribera JM; Hernández-Rivas JM
    Br J Haematol; 2016 Feb; 172(3):428-38. PubMed ID: 26567765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas.
    Soldini D; Georgis A; Montagna C; Schüffler PJ; Martin V; Curioni-Fontecedro A; Martinez A; Tinguely M
    Hematol Oncol; 2014 Sep; 32(3):120-5. PubMed ID: 24493312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3.
    Davidsson J; Andersson A; Paulsson K; Heidenblad M; Isaksson M; Borg A; Heldrup J; Behrendtz M; Panagopoulos I; Fioretos T; Johansson B
    Hum Mol Genet; 2007 Sep; 16(18):2215-25. PubMed ID: 17613536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
    Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.
    Haralambieva E; Schuuring E; Rosati S; van Noesel C; Jansen P; Appel I; Guikema J; Wabinga H; Bleggi-Torres LF; Lam K; van den Berg E; Mellink C; van Zelderen-Bhola S; Kluin P
    Genes Chromosomes Cancer; 2004 May; 40(1):10-8. PubMed ID: 15034863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
    Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
    De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
    Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The whole-genome landscape of Burkitt lymphoma subtypes.
    Panea RI; Love CL; Shingleton JR; Reddy A; Bailey JA; Moormann AM; Otieno JA; Ong'echa JM; Oduor CI; Schroeder KMS; Masalu N; Chao NJ; Agajanian M; Major MB; Fedoriw Y; Richards KL; Rymkiewicz G; Miles RR; Alobeid B; Bhagat G; Flowers CR; Ondrejka SL; Hsi ED; Choi WWL; Au-Yeung RKH; Hartmann W; Lenz G; Meyerson H; Lin YY; Zhuang Y; Luftig MA; Waldrop A; Dave T; Thakkar D; Sahay H; Li G; Palus BC; Seshadri V; Kim SY; Gascoyne RD; Levy S; Mukhopadyay M; Dunson DB; Dave SS
    Blood; 2019 Nov; 134(19):1598-1607. PubMed ID: 31558468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide search for loss of heterozygosity in Burkitt lymphoma cell lines.
    Sobol H; Benziane A; Kerangueven F; Yin L; Noguchi T; Pauly S; Eisinger F; Longy M; Romeo G; Lenoir G; Birnbaum D
    Genes Chromosomes Cancer; 2002 Feb; 33(2):217-24. PubMed ID: 11793449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.